drugset / Trial / NCT00458328

The Effect of Z-338 in Subjects With Functional Dyspepsia

NCT00458328

Phase 2 Completed 40 enrolled Zeria Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

Z-338; PhaseIIb, Single-centre, Randomized, Double-blind, Placebo-controlled, Parallel group study in Subjects with Functional Dyspepsia, evaluate the motility of gastro-duodenum by ultrasound

Timeline

Start
2007-04
Primary completion
2009-09
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Acotiamide Small molecule

Indications